2021 annual financial data

BioRestorative Therapies 2021 Net margin

Direct answer

Net margin was -96,311.51%.

Operating income was -26,307,873 USD and net income was -44,303,295 USD.
Operating cash flow was -3,329,908 USD.

Get free BioRestorative Therapies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
46,000 USD
Operating income
-26,307,873 USD
Net income
-44,303,295 USD
Operating cash flow
-3,329,908 USD